Study of Poziotinib in Participants With HER2-Positive Metastatic Breast Cancer
A phase 2 trial of Poziotinib in Breast cancer, run by Spectrum Pharmaceuticals, Inc, completed.
Overview
Study of Poziotinib in Participants With HER2-Positive Metastatic Breast Cancer is a phase 2 interventional study registered as NCT02659514 by Spectrum Pharmaceuticals, Inc, with 67 participants recorded, started 2016-02-22 and reaching its primary completion in 2020-03-11. Interventions recorded: Poziotinib. Conditions recorded: Breast Cancer.
Linked to the drug Poziotinib because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialA Study to Allow Continued Dosing and/or Follow-up of Patients Who Have Had Previous Exposure to Poziotinib
Shares Poziotinib, Spectrum Pharmaceuticals, Breast cancer (all types) and the tag pipeline.
- TrialA Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies
Shares Poziotinib, Spectrum Pharmaceuticals, Breast cancer (all types) and the tag pipeline.
- TrialA Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
Shares Spectrum Pharmaceuticals and the tag pipeline.
- TrialImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Shares Breast cancer (all types) and the tag pipeline.
- TrialCryoablation Versus Lumpectomy in Early-Stage Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- TrialPrevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
Shares Breast cancer (all types) and the tag pipeline.
- TrialComparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
Shares Breast cancer (all types) and the tag pipeline.
- TrialDiagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.